{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:06:49Z","timestamp":1792364809114,"version":"4.4.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00011-015-0806-0","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T11:39:23Z","timestamp":1425123563000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis"],"prefix":"10.1007","volume":"64","author":[{"given":"Xiao-Lei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"issue":"5","key":"806_CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11926-013-0326-2","volume":"15","author":"K Naraghi","year":"2013","unstructured":"Naraghi K, van Laar JM. Update on stem cell transplantation for systemic sclerosis: recent trial results. Curr Rheumatol Rep. 2013;15(5):326.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"806_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototype multisystem fibrotic disorder. J Clin Invest. 2007;117(3):557\u201367.","journal-title":"J Clin Invest"},{"issue":"2","key":"806_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","volume":"24","author":"J Barnes","year":"2012","unstructured":"Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol. 2012;24(2):165\u201370.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"806_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2013.01.010","volume":"31","author":"N Fett","year":"2013","unstructured":"Fett N. Scleroderma nomenclature, etiology, pathogenesis, prognosis, and treatments facts and controversies. Clin Dermatol. 2013;31(4):432\u20137.","journal-title":"Clin Dermatol"},{"issue":"10","key":"806_CR5","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","volume":"56","author":"Y Parel","year":"2007","unstructured":"Parel Y, Aurrand-Lions M, Scheja A, et\u00a0al. Presence of CD4+CD8+double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 2007;56(10):3459\u201367.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"806_CR6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3899\/jrheum.111423","volume":"39","author":"C Muangchan","year":"2012","unstructured":"Muangchan C, Pope JE. Interleukin 6 in systemic sclerosis and potential implications for targeted therapy. J Rheumatol. 2012;39(6):1120\u20134.","journal-title":"J Rheumatol"},{"issue":"2","key":"806_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/sji.12020","volume":"77","author":"PH Salim","year":"2013","unstructured":"Salim PH, Jobim M, Bredemeier M, et\u00a0al. Interleukin-10 gene promoter and NFKB1 promoter insertion\/deletion polymorphisms in systemic sclerosis. Scand J Immunol. 2013;77(2):162\u20138.","journal-title":"Scand J Immunol"},{"issue":"3","key":"806_CR8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cyto.2011.08.030","volume":"56","author":"P Fuschiotti","year":"2011","unstructured":"Fuschiotti P. Role of IL-13 in systemic sclerosis. Cytokine. 2011;56(3):544\u20139.","journal-title":"Cytokine"},{"key":"806_CR9","author":"ME Truchetet","year":"2013","unstructured":"Truchetet ME, Brembilla NC, Montanari E, et\u00a0al. Interleukin-17A+cells are increased in systemic sclerosis skin and their number is inversely correlated to the extent of skin involvement. Arthritis Rheum. 2013;. doi: 10.1002\/art.37860 .","journal-title":"Arthritis Rheum"},{"issue":"4","key":"806_CR10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","volume":"15","author":"Y Pehlivan","year":"2012","unstructured":"Pehlivan Y, Onat AM, Ceylan N, et\u00a0al. Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis. 2012;15(4):374\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"806_CR11","first-page":"487","volume":"25","author":"N Giordano","year":"2011","unstructured":"Giordano N, Papakostas P, Pecetti G, et\u00a0al. Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis. J Biol Regul Homeost Agents. 2011;25(4):487\u201392.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1\u20134","key":"806_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830189809084486","volume":"17","author":"P Chomarat","year":"1998","unstructured":"Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17(1\u20134):1\u201352.","journal-title":"Int Rev Immunol"},{"issue":"3","key":"806_CR13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbrc.2011.12.069","volume":"417","author":"X Yao","year":"2012","unstructured":"Yao X, Zha W, Song W, et\u00a0al. Coordinated regulation of IL-4 and IL-13 expression in human T cells: 3C analysis for DNA looping. Biochem Biophys Res Commun. 2012;417(3):996\u20131001.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"806_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri2735","volume":"10","author":"WE Paul","year":"2010","unstructured":"Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10(4):225\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"806_CR15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ni.2182","volume":"13","author":"HE Liang","year":"2011","unstructured":"Liang HE, Reinhardt RL, Bando JK, et\u00a0al. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2011;13(1):58\u201366.","journal-title":"Nat Immunol"},{"issue":"9","key":"806_CR16","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/eji.201142227","volume":"42","author":"E Gallo","year":"2012","unstructured":"Gallo E, Katzman S, Villarino AV. IL-13-producing Th1 and Th17 cells characterize adaptive responses to both self and foreign antigens. Eur J Immunol. 2012;42(9):2322\u20138.","journal-title":"Eur J Immunol"},{"key":"806_CR17","doi-asserted-by":"crossref","unstructured":"Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal. 2008;1(51):pe55","DOI":"10.1126\/scisignal.1.51.pe55"},{"issue":"5","key":"806_CR18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11882-007-0051-x","volume":"7","author":"Y Tabata","year":"2007","unstructured":"Tabata Y, Khurana Hershey GK. IL-13 receptor isoforms: breaking through the complexity. Curr Allergy Asthma Rep. 2007;7(5):338\u201345.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"806_CR19","doi-asserted-by":"crossref","first-page":"e55788","DOI":"10.1371\/journal.pone.0055788","volume":"8","author":"DK Wijesundara","year":"2013","unstructured":"Wijesundara DK, Tscharke DC, Jackson RJ, et\u00a0al. Reduced interleukin-4 receptor \u03b1 expression on CD8\u00a0+\u00a0T cells correlates with higher quality anti-viral immunity. PLoS One. 2013;8(1):e55788.","journal-title":"PLoS One"},{"issue":"3","key":"806_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jmr.2150","volume":"25","author":"ER Lacy","year":"2012","unstructured":"Lacy ER. Equilibrium and kinetic analysis of human interleukin-13 and IL-13 receptor alpha-2 complex formation. J Mol Recognit. 2012;25(3):184\u201391.","journal-title":"J Mol Recognit"},{"key":"806_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(00)80677-9","volume":"4","author":"JJ Ryan","year":"1996","unstructured":"Ryan JJ, McReynolds LJ, Keegan A, et\u00a0al. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity. 1996;4:123\u201332.","journal-title":"Immunity"},{"issue":"111","key":"806_CR22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mai.2003.1333","volume":"4","author":"GK Hershey","year":"2003","unstructured":"Hershey GK. IL-13 receptors and signaling pathways: an evolving web. Allergy Clin Immunol. 2003;4(111):677\u201390.","journal-title":"Allergy Clin Immunol"},{"issue":"5625","key":"806_CR23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.1085458","volume":"300","author":"AE Kelly-Welch","year":"2003","unstructured":"Kelly-Welch AE, Hanson EM, Boothby MR, et\u00a0al. Interleukin-4 and interleukin-13 signaling connections maps. Science. 2003;300(5625):1527\u20138.","journal-title":"Science"},{"key":"806_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/377173a0","volume":"377","author":"XJ Sun","year":"1995","unstructured":"Sun XJ, Wang LM, Zhang Y, et\u00a0al. Role of IRS-2 in insulin and cytokine signaling. Nature. 1995;377:173\u20137.","journal-title":"Nature"},{"key":"806_CR25","first-page":"119","volume":"53","author":"MF White","year":"1998","unstructured":"White MF. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res. 1998;53:119\u201338.","journal-title":"Recent Prog Horm Res"},{"key":"806_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2012.10.553","volume":"54","author":"A Bhattacharjee","year":"2013","unstructured":"Bhattacharjee A, Shukla M, Yakubenko VP, et\u00a0al. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes\/macrophages. Free Radic Biol Med. 2013;54:1\u201316.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"806_CR27","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1084\/jem.20080452","volume":"205","author":"IS Junttila","year":"2008","unstructured":"Junttila IS, Mizukami K, Dickensheets H, et\u00a0al. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4R\u03b1, IL-13R\u03b11, and \u03b3c regulates relative cytokine sensitivity. J Exp Med. 2008;205(11):2595\u2013608.","journal-title":"J Exp Med"},{"issue":"12","key":"806_CR28","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1039\/c3mb70298g","volume":"9","author":"AL Andrews","year":"2013","unstructured":"Andrews AL, Nordgren IK, Campbell-Harding G, et\u00a0al. The association of the cytoplasmic domains of interleukin-4 receptor alpha and interleukin-13 receptor alpha 2 regulates interleukin-4 signaling. Mol BioSyst. 2013;9(12):3009\u201314.","journal-title":"Mol BioSyst"},{"key":"806_CR29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA. Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol. 2004;4:583\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"806_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvs142","volume":"95","author":"P Kanellakis","year":"2012","unstructured":"Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res. 2012;95(1):77\u201385.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"806_CR31","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.4049\/jimmunol.170.4.2083","volume":"170","author":"F Huaux","year":"2003","unstructured":"Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH. Dual roles of IL-4 in lung injury and fibrosis. J Immunol. 2003;170(4):2083\u201392.","journal-title":"J Immunol"},{"issue":"2","key":"806_CR32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000073718","volume":"132","author":"A Saito","year":"2003","unstructured":"Saito A, Okazaki H, Sugawara I, Yamamoto K. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol. 2003;132(2):168\u201376.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"806_CR33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1478-3231.2005.01087.x","volume":"25","author":"R Sugimoto","year":"2005","unstructured":"Sugimoto R, Enjoji M, Nakamuta M, Ohta S. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 2005;25(2):420\u20138.","journal-title":"Liver Int"},{"key":"806_CR34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1159\/000065451","volume":"92","author":"M Sommer","year":"2002","unstructured":"Sommer M, Eismann U, Gerth J, Stein G. Interleukin 4 co-stimulates the PDGF-BB and bFGF-mediated proliferation of mesangial cells and myofibroblasts. Nephron. 2002;92:868\u201380.","journal-title":"Nephron"},{"key":"806_CR35","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.152.7.3606","volume":"152","author":"GD Sempowski","year":"1994","unstructured":"Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol. 1994;152:3606\u201314.","journal-title":"J Immunol"},{"key":"806_CR36","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI116015","volume":"90","author":"AE Postlethwaite","year":"1992","unstructured":"Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992;90:1479\u201385.","journal-title":"J Clin Invest"},{"key":"806_CR37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/labinvest.2008.61","volume":"88","author":"L Aoudjehane","year":"2008","unstructured":"Aoudjehane L, Pissaia A Jr, Scatton O, Podevin P, Massault PP, Chouzenoux S, et\u00a0al. Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the stat-6 pathway. Lab Invest. 2008;88:973\u201385.","journal-title":"Lab Invest"},{"issue":"8","key":"806_CR38","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/art.11089","volume":"48","author":"TL McGaha","year":"2003","unstructured":"McGaha TL, Le M, Kodera T, Stoica C. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum. 2003;48(8):2275\u201384.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"806_CR39","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.4049\/jimmunol.171.7.3550","volume":"171","author":"MW Wynes","year":"2003","unstructured":"Wynes MW, Riches DW. Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13. J Immunol. 2003;171(7):3550\u20139.","journal-title":"J Immunol"},{"issue":"5","key":"806_CR40","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1189\/jlb.0504288","volume":"76","author":"MW Wynes","year":"2004","unstructured":"Wynes MW, Franke SK, Riches DW. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol. 2004;76(5):1019\u201327.","journal-title":"J Leukoc Biol"},{"key":"806_CR41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1204351","volume":"332","author":"SJ Jenkins","year":"2011","unstructured":"Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N, et\u00a0al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of Th2 inflammation. Science. 2011;332:1284\u20138.","journal-title":"Science"},{"key":"806_CR42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593\u2013604.","journal-title":"Immunity"},{"key":"806_CR43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ajpath.2010.11.065","volume":"178","author":"S Prokop","year":"2011","unstructured":"Prokop S, Heppner FL, Goebel HH, Stenzel W. M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am J Pathol. 2011;178:1279\u201386.","journal-title":"Am J Pathol"},{"issue":"2","key":"806_CR44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/mi.2011.60","volume":"5","author":"A Bellini","year":"2012","unstructured":"Bellini A, Marini MA, Bianchetti L, Barczyk M, Schmidt M, Mattoli S. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol. 2012;5(2):140\u20139.","journal-title":"Mucosal Immunol"},{"key":"806_CR45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0002-9440(10)63330-5","volume":"165","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol. 2004;165:659\u201369.","journal-title":"Am J Pathol"},{"issue":"2","key":"806_CR46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1183\/09031936.00068712","volume":"43","author":"R Firszt","year":"2014","unstructured":"Firszt R, Francisco D, Church TD, Thomas JM. Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-\u03b21 in airway fibroblasts in asthma. Eur Respir J. 2014;43(2):464\u201373.","journal-title":"Eur Respir J"},{"issue":"2","key":"806_CR47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1478-3231.2005.01087.x","volume":"25","author":"R Sugimoto","year":"2005","unstructured":"Sugimoto R, Enjoji M, Nakamuta M, Ohta S. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 2005;25(2):420\u20138.","journal-title":"Liver Int"},{"issue":"3 Suppl","key":"806_CR48","doi-asserted-by":"crossref","first-page":"422S","DOI":"10.1378\/chest.123.3_suppl.422S","volume":"123","author":"JL Ingram","year":"2003","unstructured":"Ingram JL, Rice A, Geisenhoffer K, Madtes DK. Interleukin-13 stimulates the proliferation of lung myofibroblasts via a signal transducer and activator of transcription-6-dependent mechanism: a possible mechanism for the development of airway fibrosis in asthma. Chest. 2003;123(3 Suppl):422S\u20134S.","journal-title":"Chest"},{"issue":"4","key":"806_CR49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12038-014-9454-8","volume":"39","author":"J Lu","year":"2014","unstructured":"Lu J, Zhu Y, Feng W, Pan Y. Platelet-derived growth factor mediates interleukin-13-induced collagen I production in mouse airway fibroblasts. J Biosci. 2014;39(4):693\u2013700.","journal-title":"J Biosci"},{"issue":"6","key":"806_CR50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee CG, Homer RJ, Zhu Z, Lanone S. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta (1). J Exp Med. 2001;194(6):809\u201321.","journal-title":"J Exp Med"},{"issue":"1","key":"806_CR51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","volume":"12","author":"S Fichtner-Feigl","year":"2006","unstructured":"Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2006;12(1):99\u2013106.","journal-title":"Nat Med"},{"issue":"6","key":"806_CR52","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.173.6.4020","volume":"173","author":"M Kaviratne","year":"2004","unstructured":"Kaviratne M, Hesse M, Leusink M, Cheever AW. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol. 2004;173(6):4020\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"806_CR53","first-page":"328","volume":"24","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol. 1997;24(2):328\u201332.","journal-title":"J Rheumatol"},{"issue":"7","key":"806_CR54","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","volume":"132","author":"V Salmon-Ehr","year":"1996","unstructured":"Salmon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, Birembaut P, Maquart FX. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol. 1996;132(7):802\u20136.","journal-title":"Arch Dermatol"},{"issue":"1","key":"806_CR55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/art.21497","volume":"54","author":"JH Distler","year":"2006","unstructured":"Distler JH, J\u00fcngel A, Caretto D, et\u00a0al. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum. 2006;54(1):214\u201325.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"806_CR56","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M","volume":"28","author":"C Ong","year":"1998","unstructured":"Ong C, Wong C, Roberts CR, Teh HS, Jirik FR. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur J Immunol. 1998;28(9):2619\u201329.","journal-title":"Eur J Immunol"},{"issue":"3","key":"806_CR57","doi-asserted-by":"crossref","first-page":"e33508","DOI":"10.1371\/journal.pone.0033508","volume":"7","author":"N Binai","year":"2012","unstructured":"Binai N, O\u2019Reilly S, Griffiths B, et\u00a0al. Differentiation potential of CD4\u00a0+\u00a0monocytes into myofibroblasts in patients with systemic sclerosis. PLoS One. 2012;7(3):e33508.","journal-title":"PLoS One"},{"issue":"2","key":"806_CR58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0923-1811(95)00469-6","volume":"12","author":"KS Lee","year":"1996","unstructured":"Lee KS, Ro YJ, Ryoo YW, Kwon HJ, Song JY. Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture. J Dermatol Sci. 1996;12(2):110\u20137.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"806_CR59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-012-0297-8","volume":"15","author":"MB Greenblatt","year":"2013","unstructured":"Greenblatt MB, Aliprantis AO. The immune pathogenesis of scleroderma: context is everything. Curr Rheumatol Rep. 2013;15(1):297.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"806_CR60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10067-002-0684-z","volume":"22","author":"V Riccieri","year":"2003","unstructured":"Riccieri V, Rinaldi T, Spadaro A, Scrivo R, Ceccarelli F, Franco MD, Taccari E, Valesini G. Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol. 2003;22(2):102\u20136.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"806_CR61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000071783","volume":"207","author":"M Hasegawa","year":"2003","unstructured":"Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology. 2003;207(2):141\u20137.","journal-title":"Dermatology"},{"issue":"6","key":"806_CR62","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.30318","volume":"63","author":"RB Christmann","year":"2011","unstructured":"Christmann RB, Hayes E, Pendergrass S, Padilla C, Farina G, Affandi AJ, Whitfield ML, Farber HW, Lafyatis R. Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. Arthritis Rheum. 2011;63(6):1718\u201328.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"806_CR63","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","volume":"60","author":"P Fuschiotti","year":"2009","unstructured":"Fuschiotti P, Medsger TA, Morel PA. Effector CD8+T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum. 2009;60(4):1119\u201328.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"806_CR64","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.30489","volume":"63","author":"TA Medsger Jr","year":"2011","unstructured":"Medsger TA Jr, Ivanco DE, Kardava L, et\u00a0al. GATA-3 upregulation in CD8+T cells is a biomarker of immune dysfunction in systemic sclerosis, resulting in excess IL-13 production. Arthritis Rheum. 2011;63(6):1738\u201347.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"806_CR65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3899\/jrheum.110235","volume":"39","author":"JC Broen","year":"2012","unstructured":"Broen JC, Dieude P, Vonk MC, et\u00a0al. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression. J Rheumatol. 2012;39(1):112\u20138.","journal-title":"J Rheumatol"},{"key":"806_CR66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00251-006-0135-0","volume":"58","author":"B Granel","year":"2006","unstructured":"Granel B, Chevillard C, Allanore Y, et\u00a0al. Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics. 2006;58:693\u20139.","journal-title":"Immunogenetics"},{"key":"806_CR67","first-page":"2015","volume":"33","author":"B Granel","year":"2006","unstructured":"Granel B, Allanore Y, Chevillard C, et\u00a0al. IL13RA2 gene polymorphisms are associated with systemic sclerosis. J Rheumatol. 2006;33:2015\u20139.","journal-title":"J Rheumatol"},{"issue":"12","key":"806_CR68","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0962-8924(00)01856-0","volume":"10","author":"Anne O\u2019Garra","year":"2000","unstructured":"O\u2019Garra Anne, Arai Naoko. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 2000;10(12):542\u201350.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"806_CR69","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.4049\/jimmunol.1300567","volume":"191","author":"L Lombardelli","year":"2013","unstructured":"Lombardelli L, Aguerre-Girr M, Logiodice F, et\u00a0al. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4+T cells and macrophages. J Immunol. 2013;191(7):3651\u201362.","journal-title":"J Immunol"},{"key":"806_CR70","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.1002778","volume":"186","author":"Etsushi Kuroda","year":"2011","unstructured":"Kuroda Etsushi, Antignano Frann, Ho Victor W, et\u00a0al. SHIP represses Th2 skewing by inhibiting IL-4 production from basophils. J Immunol. 2011;186:323\u201332.","journal-title":"J Immunol"},{"key":"806_CR71","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4049\/jimmunol.0902182","volume":"185","author":"JL Cannons","year":"2010","unstructured":"Cannons JL, Wu JZ, Gomez-Rodriguez J, et\u00a0al. Biochemical and genetic evidence for a SAP-PKC-\u03b8 interaction contributing to IL-4 regulation. J Immunol. 2010;185:2819\u201327.","journal-title":"J Immunol"},{"issue":"3","key":"806_CR72","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cyto.2012.08.009","volume":"60","author":"S Bruhn","year":"2012","unstructured":"Bruhn S, Katzenellenbogen M, Gustafsson M, et\u00a0al. Combining gene expression microarray- and cluster analysis with sequence-based predictions to identify regulators of IL-13 in allergy. Cytokine. 2012;60(3):736\u201340.","journal-title":"Cytokine"},{"issue":"5","key":"806_CR73","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2011.04.034","volume":"128","author":"Manish Kumar","year":"2011","unstructured":"Kumar Manish, Ahmad Tanveer, Sharma Amit, et\u00a0al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immun. 2011;128(5):1077\u201385.","journal-title":"J Allergy Clin Immun"},{"issue":"6","key":"806_CR74","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.immuni.2010.06.011","volume":"32","author":"LL Elo","year":"2010","unstructured":"Elo LL, J\u00e4rvenp\u00e4\u00e4 H, Tuomela S, et\u00a0al. Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming. Immunity. 2010;32(6):852\u201362.","journal-title":"Immunity"},{"key":"806_CR75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/IR:28:1:25","volume":"28","author":"M Zhou","year":"2003","unstructured":"Zhou M, Ouyang W. The function role of GATA-3 in Th1 and Th2 Differentiation. Immunol Res. 2003;28:25\u201337.","journal-title":"Immunol Res"},{"key":"806_CR76","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","volume":"51","author":"S O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly S, H\u00fcgle T, van Laar JM. T cells in systemic sclerosis: a reappraisal. Rheumatology. 2012;51:1540\u20139.","journal-title":"Rheumatology"},{"issue":"3","key":"806_CR77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clim.2011.08.010","volume":"141","author":"AA Divekar","year":"2011","unstructured":"Divekar AA, Khanna D, Abtin F, Maranian P, Saggar R, Saggar R, Furst DE, Singh RR. Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis. Clin Immunol. 2011;141(3):293\u2013303.","journal-title":"Clin Immunol"},{"issue":"3","key":"806_CR78","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jmb.2012.11.036","volume":"425","author":"D Lightwood","year":"2013","unstructured":"Lightwood D, O\u2019Dowd V, Carrington B, et\u00a0al. The discovery, engineering and characterisation of a highly potent anti-human IL-13 fab fragment designed for administration by inhalation. J Mol Biol. 2013;425(3):577\u201393.","journal-title":"J Mol Biol"},{"issue":"3","key":"806_CR79","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajpath.2011.11.024","volume":"180","author":"MB Greenblatt","year":"2012","unstructured":"Greenblatt MB, Sargent JL, Farina G, et\u00a0al. Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. Am J Pathol. 2012;180(3):1080\u201394.","journal-title":"Am J Pathol"},{"issue":"6","key":"806_CR80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10067-012-1962-z","volume":"31","author":"M Brown","year":"2012","unstructured":"Brown M, Postlethwaite AE, Myers LK, et\u00a0al. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts. Clin Rheumatol. 2012;31(6):973\u201381.","journal-title":"Clin Rheumatol"},{"key":"806_CR81","unstructured":"Christmann RB, Mathes A, Affandi AJ, et\u00a0al. TSLP upregulation in human SSc skin and induction of overlapping profibrotic genes and intracelullar signaling with IL-13 and TGF\u03b2. Arthritis Rheum. 2013; doi: 10.1002"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-015-0806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-015-0806-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-015-0806-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T14:29:24Z","timestamp":1691504964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-015-0806-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":81,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s00011-015-0806-0","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,1]]}}}